Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
Abstract Hyperglycemia and rash are expected but challenging adverse events of phosphatidylinositol-3-kinase inhibition (such as with alpelisib). Two modified Delphi panels were conducted to provide consensus recommendations for managing hyperglycemia and rash in patients taking alpelisib. Experts r...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-024-00613-x |